Topic
Drug Regulation
188 published works
Australian Emergency Law
NSW Pharmaceutical services fail to mention paramedics in legislation update
By M. Eburn
I have previously reported that there are new drugs laws coming into force in NSW on 5 November 2026 – see Changes coming to NSW drug legislation (July 12, 2026). I signed up…
Dispute Resolution Blog
Enforcement vs. Due Process: Lessons from the FDA–Cadila Matter on Drug Regulation in Maharashtra
By Vineet Unnikrishnan, Sonu Bhasi, Karthika Sanjay
Summary – At a time when drug regulators are intensifying enforcement against the sector across India, this article examines the regulatory framework within which drug regulators are required to act…
Big Molecule Watch
FDA Revises Draft Guidance on Substantial Evidence of Effectiveness to Clarify Confirmatory Evidence Requirements for a Single Clinical Investigation
On June 25, 2026, the U.S. Food and Drug Administration (FDA) announced the availability of revised draft guidance titled “Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products.” …
Canna Law Blog
What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E
What California operators must do after rescheduling: DEA registration, license restructuring, and 280E On April 23, 2026, the DOJ and DEA issued a final order rescheduling certain marijuana products from…
UK Human Rights Blog
Fake GLP-1 jabs: no more advertising on the internet
Novo Nordisk and others v BT and others [2026] EWHC 1553 (CH) News just in: The UK’s drug regulator has approved a daily pill version of the obesity drug semaglutide…
GoodLifeSci
FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight Paradigm
By Raj D. Pai, Jaclyn G. Fonteyne, Andrew James, Julea Lipiz
Recent United States Food and Drug Administration (FDA) announcements continue to highlight the agency’s increasing development and use of artificial intelligence. Earlier this month, FDA announced the launch of the…
Life Sciences Perspectives
FDA Signals Potentially Evolving Stance Toward Compounding of Certain Peptides
By Javier González-Rivera|Susan Lee
On April 15, 2026, the U.S. Food and Drug Administration (“FDA”) announced that it will convene a public meeting of the Pharmacy Compounding Advisory Committee (“PCAC”) on July 23-24, 2026,…
JURIST
US federal judge pauses Louisiana attempt to restrict abortion pill access
By Ben Golin | U. Nevada School Of Law, US
A federal judge on Tuesday paused Louisiana’s bid to reinstate stricter dispensing rules for the abortion pill mifepristone, staying the case while the Food and Drug Administration (FDA) conducts an…
China Law Insight
《中华人民共和国药品管理法实施条例》修订要点解读
By King & Wood
作者:黄建雯 朱昕彤 聂轩 《药品管理法实施条例》(“《条例》”)是《药品管理法》的重要配套行政法规。现行《条例》于2002年公布施行,主要内容包括药品生产企业管理、药品经营企业管理、医疗机构的药剂管理、药品管理、药品包装的管理、药品价格和广告的管理、药品监督和法律责任等。现行《条例》自公布以来,曾于2016年、2019年、2024年进行过三次局部技术性调整。 阅读更多
Global Policy Watch
EU Announces Political Agreement on Pharma Law Review
By Grant Castle, Peter Bogaert, Robin Blaney, Marie Doyle-Rossi, Anna Wawrzyniak, Spiros Drosos
At just after 5 am on 11 December 2025, the EU Parliament and the Council reached agreement on a new directive and a new regulation that will result in a…